BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31152000)

  • 1. Intestinal basolateral lipid substrate transport is linked to chylomicron secretion and is regulated by apoC-III.
    Li D; Rodia CN; Johnson ZK; Bae M; Muter A; Heussinger AE; Tambini N; Longo AM; Dong H; Lee JY; Kohan AB
    J Lipid Res; 2019 Sep; 60(9):1503-1515. PubMed ID: 31152000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using primary murine intestinal enteroids to study dietary TAG absorption, lipoprotein synthesis, and the role of apoC-III in the intestine.
    Jattan J; Rodia C; Li D; Diakhate A; Dong H; Bataille A; Shroyer NF; Kohan AB
    J Lipid Res; 2017 May; 58(5):853-865. PubMed ID: 28159868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma.
    Björkegren J; Karpe F; Milne RW; Hamsten A
    J Lipid Res; 1998 Jul; 39(7):1412-20. PubMed ID: 9684744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human intestinal lipoproteins. Studies in chyluric subjects.
    Green PH; Glickman RM; Saudek CD; Blum CB; Tall AR
    J Clin Invest; 1979 Jul; 64(1):233-42. PubMed ID: 221544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WAT apoC-I secretion: role in delayed chylomicron clearance in vivo and ex vivo in WAT in obese subjects.
    Cyr Y; Wassef H; Bissonnette S; Lamantia V; Davignon J; Faraj M
    J Lipid Res; 2016 Jun; 57(6):1074-85. PubMed ID: 27040450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of apolipoprotein A-IV enhances lipid secretion in IPEC-1 cells by increasing chylomicron size.
    Lu S; Yao Y; Cheng X; Mitchell S; Leng S; Meng S; Gallagher JW; Shelness GS; Morris GS; Mahan J; Frase S; Mansbach CM; Weinberg RB; Black DD
    J Biol Chem; 2006 Feb; 281(6):3473-83. PubMed ID: 16338933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key differences between apoC-III regulation and expression in intestine and liver.
    West G; Rodia C; Li D; Johnson Z; Dong H; Kohan AB
    Biochem Biophys Res Commun; 2017 Sep; 491(3):747-753. PubMed ID: 28739253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36.
    Hsieh J; Longuet C; Maida A; Bahrami J; Xu E; Baker CL; Brubaker PL; Drucker DJ; Adeli K
    Gastroenterology; 2009 Sep; 137(3):997-1005, 1005.e1-4. PubMed ID: 19482026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women.
    Wassef H; Bissonnette S; Dufour R; Davignon J; Faraj M
    J Nutr; 2017 May; 147(5):754-762. PubMed ID: 28356429
    [No Abstract]   [Full Text] [Related]  

  • 10. A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels.
    Khetarpal SA; Zeng X; Millar JS; Vitali C; Somasundara AVH; Zanoni P; Landro JA; Barucci N; Zavadoski WJ; Sun Z; de Haard H; Toth IV; Peloso GM; Natarajan P; Cuchel M; Lund-Katz S; Phillips MC; Tall AR; Kathiresan S; DaSilva-Jardine P; Yates NA; Rader DJ
    Nat Med; 2017 Sep; 23(9):1086-1094. PubMed ID: 28825717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Missense mutation in APOC3 within the C-terminal lipid binding domain of human ApoC-III results in impaired assembly and secretion of triacylglycerol-rich very low density lipoproteins: evidence that ApoC-III plays a major role in the formation of lipid precursors within the microsomal lumen.
    Qin W; Sundaram M; Wang Y; Zhou H; Zhong S; Chang CC; Manhas S; Yao EF; Parks RJ; McFie PJ; Stone SJ; Jiang ZG; Wang C; Figeys D; Jia W; Yao Z
    J Biol Chem; 2011 Aug; 286(31):27769-80. PubMed ID: 21676879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-day mouse mesenteric lymph surgery in mice: an updated approach to study dietary lipid absorption, chylomicron secretion, and lymphocyte dynamics.
    Dedousis N; Teng L; Kanshana JS; Kohan AB
    J Lipid Res; 2022 Nov; 63(11):100284. PubMed ID: 36152881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E.
    de Silva HV; Lauer SJ; Wang J; Simonet WS; Weisgraber KH; Mahley RW; Taylor JM
    J Biol Chem; 1994 Jan; 269(3):2324-35. PubMed ID: 8294490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice.
    Jong MC; Rensen PC; Dahlmans VE; van der Boom H; van Berkel TJ; Havekes LM
    J Lipid Res; 2001 Oct; 42(10):1578-85. PubMed ID: 11590213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions.
    Zheng C; Khoo C; Ikewaki K; Sacks FM
    J Lipid Res; 2007 May; 48(5):1190-203. PubMed ID: 17314277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance.
    Ramms B; Patel S; Nora C; Pessentheiner AR; Chang MW; Green CR; Golden GJ; Secrest P; Krauss RM; Metallo CM; Benner C; Alexander VJ; Witztum JL; Tsimikas S; Esko JD; Gordts PLSM
    J Lipid Res; 2019 Aug; 60(8):1379-1395. PubMed ID: 31092690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triglyceride-rich lipoprotein metabolism in women: roles of apoC-II and apoC-III.
    Ooi EM; Chan DC; Hodson L; Adiels M; Boren J; Karpe F; Fielding BA; Watts GF; Barrett PH
    Eur J Clin Invest; 2016 Aug; 46(8):730-6. PubMed ID: 27378472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of apolipoprotein C-III decreases secretion of dietary triglyceride into lymph.
    Wang F; Kohan AB; Dong HH; Yang Q; Xu M; Huesman S; Lou D; Hui DY; Tso P
    Physiol Rep; 2014; 2(3):e00247. PubMed ID: 24760506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype.
    Zheng C; Khoo C; Furtado J; Sacks FM
    Circulation; 2010 Apr; 121(15):1722-34. PubMed ID: 20368524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very low density lipoproteins in intestinal lymph: role in triglyceride and cholesterol transport during fat absorption.
    Ockner RK; Hughes FB; Isselbacher KJ
    J Clin Invest; 1969 Dec; 48(12):2367-73. PubMed ID: 5355348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.